RecruitingPeripheral Arterial Disease
Carnosine for Peripheral Arterial Disease Patients
Eligible age
50–80 yrs
Accepts
Men
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Oral supplementation of L-carnosine will increase muscle carnosine, stabilize HIF1-alpha promote angiogenesis, and thus improve the functioning of lower extremities in PAD patients.
Sponsor: Shahid Baba
You may qualify if…
- ✓ 1. Male subjects more than \>50 to \<80 years of age.
- ✓ 2. White or African American race.
- ✓ 3. English Speaking.
- ✓ 4. ABI 0.4-\< 0.60
- ✓ 5. Willing to comply with protocol requirements.
- ✓ 6. Able to provide informed consent. -
You may not qualify if…
- ✕ 1. Subjects with HIV, hepatitis, significant liver disease, active infection, anemia, organ transplant, renal disease requiring dialysis, lung disease requiring oxygen, significant congenital heart disease, cancer of any type, and untreated thyroid disease.
- ✕ 2. Diagnosis of carnosinemia.
- ✕ 3. Known allergy to L-carnosine or meat.
- ✕ 4. Presence of a pacemaker.
- ✕ 5. Obesity from a known genetic defect.
- ✕ 6. Dementia.
- ✕ 7. Critical limb ischemia with below or above knee amputations.
- ✕ 8. Foot ulcers.
Where it's recruiting
Kentucky
Louisville
Source: ClinicalTrials.gov · NCT05371145 · last updated 2024-07-22